T

TG Therapeutics, Inc. Tech Stack

FDA-approved biotech for B-cell diseases, scaling commercial operations

Biotechnology Research Morrisville, North Carolina 201–500 employees Founded 2011 Public Company

TG Therapeutics operates a commercialized biotech platform with FDA approval for relapsing multiple sclerosis and an active pipeline targeting B-cell diseases. The hiring pattern (support roles dominating, mixed management and director-level seniority) paired with operational projects (inventory automation, ERP tooling, clinical audit programs, reimbursement workflows) reveals a company in post-approval phase—shifting from pure R&D to building supply-chain, patient-access, and quality infrastructure. Tech stack is lightweight (Laravel, React, Node.js), appropriate for internal operations rather than product-facing complexity.

Tech Stack 10 technologies

Core StackLaravel PHP JavaScript React Node.js CI/CD Git

What TG Therapeutics, Inc. Is Building

◆Challenges

Improving inventory and cogs accounting processes
Inventory reporting automation
Workflow gaps
Case escalations
Reimbursement policy trends
Reducing access and reimbursement challenges
Optimizing case management performance
Identifying process inefficiencies
Training gaps
Vendor compliance

▲Active Projects

Continuous learning initiatives
Inventory reporting tools and automation in erp
Physical inventory count process
Annual clinical site audit program
Gcp inspection readiness projects
Quality assurance strategy development
Programmatic audit execution
Corrective action plan implementation
Patient access program enhancements
Process gap analysis

Hiring Activity

Accelerating10 roles · 7 in 30d

Department

Support

4

Engineering

1

Finance

1

Legal

1

Manufacturing

1

Research

1

Security

1

Seniority

Manager

4

Director

3

Senior

2

Junior

1

Company intelligence

Find more companies like TG Therapeutics, Inc. by tech stack, pain points and active projects

Get started free

About TG Therapeutics, Inc.

TG Therapeutics is a publicly traded biotech company headquartered in Morrisville, North Carolina, focused on acquiring, developing, and commercializing treatments for B-cell diseases. The company has secured FDA approval and multiple international regulatory clearances for its lead therapy in relapsing multiple sclerosis. With 201–500 employees, TG operates as a fully integrated, commercial-stage business—handling R&D, regulatory affairs, manufacturing, patient access, and sales. Recent hiring velocity indicates expansion in support functions, finance, manufacturing, and quality assurance, aligning with the operational demands of drug commercialization and inventory management.

HeadquartersMorrisville, North Carolina

Company Size201–500 employees

Founded2011

Hiring MarketsUnited States, Canada

Frequently Asked Questions

What is TG Therapeutics' approved therapy?

TG Therapeutics has received FDA approval and international regulatory clearance for a therapy treating relapsing multiple sclerosis (RMS). The company specializes in B-cell disease treatments, with its approved therapy representing the commercial foundation of the platform.

Where is TG Therapeutics headquartered?

TG Therapeutics is headquartered in Morrisville, North Carolina, and is a publicly traded company founded in 2011. The company actively hires in the United States and Canada.